Antiprogestin Testing Act of 1992
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Antiprogestin Testing Act of 1992 - Directs the Secretary of Health and Human Services to conduct and support research, including clinical trials, on antiprogestin drug safety and efficacy for any potential use, including termination of pregnancy, contraception, and therapeutic use for cancer, endocrine disorders, and endometriosis. Makes the research subject to provisions relating to institutional review boards and peer review.
Referred to the Subcommittee on Health and the Environment.
- Introduced in House Formatted Text
Cite this page
U.S. Congress. (2026). H.R. 6178: Antiprogestin Testing Act of 1992. 102nd Congress. Open America. https://openamerica.io/bill/102-HR-6178/
"H.R. 6178: Antiprogestin Testing Act of 1992." 102nd Congress, 2026, Open America, https://openamerica.io/bill/102-HR-6178/.
H.R. 6178, 102nd Cong. (2026), https://openamerica.io/bill/102-HR-6178/.
[H.R. 6178: Antiprogestin Testing Act of 1992](https://openamerica.io/bill/102-HR-6178/)